Eggciting news, launching of the Eggcheff!
Glycostem raises capital for phase I/IIa clinical trials
Amphera recruits first patients to phase II study of MesoPher to treat pancreatic cancer
Amphera wins top ten list of most groundbreaking innovations in science
Amphera recruits first patients to pivotal phase II/III study of MesoPher to treat pleural mesothelioma